Keyword: Pfizer


Viatris Forms Eye Care Unit from Acquisitions

10.01.2023 -

Viatris, formed in November 2020 from the merger of Mylan with Pfizer’s Upjohn division, has established an eye care division following the closure of two acquisitions on...


Chinese Distributor Inks Paxlovid Deal with Pfizer

16.12.2022 -

As Covid cases continue to explode across the country, China Meheco Group Co, an internationally active manufacturer and distributor of pharmaceuticals chemicals and...


Pfizer to Invest $750 million in Michigan

15.12.2022 -

Pfizer is planning to invest $750 million in its Kalamazoo County, Michigan, production site – one of its biggest – to increase output of injectables and vaccines...


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


Pfizer Doubles Dublin Biologicals Capacity

06.12.2022 -

Pfizer has announced plans to invest more than €1.2 billion at its site in Grange Castle, Dublin, Ireland, to double capacity for biological drug substances.


Pfizer/BioNTech Bivalent Covid Booster Wins Approvals

10.11.2022 -

UK health regulator Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech bivalent Covid-19 vaccine for use as a booster in people...


Omicron-targeted Covid Boosters may not be Better

28.10.2022 -

The newly launched bivalent mRNA-based Covid-19 booster shots from Moderna and Pfizer/BioNTech did not show a major improvement over the companies’ first-generation...


EU Public Prosecutor Probes Vaccine Mega Order

20.10.2022 -

The European Public Prosecutors Office (EPPO) has confirmed that it is looking into the EU Commission’s ordering of Covid-19 vaccines, with the probe thought to pertain...